Standout Papers

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour afte... 2006 2026 2012 2019 1.9k
  1. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial (2006)
    George D. Demetri, Allan T. van Oosterom et al. The Lancet
  2. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib (2007)
    Tammy F. Chu, Maria A. Rupnick et al. The Lancet
  3. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma (2017)
    Suzanne George, Diana Miao et al. Immunity
  4. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial (2020)
    Jean‐Yves Blay, César Serrano et al. The Lancet Oncology

Immediate Impact

2 by Nobel laureates 13 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Antitumour immunity regulated by aberrant ERBB family signalling
2021 Standout
Toward personalized treatment approaches for non-small-cell lung cancer
2021 Standout

Works of Suzanne George being referenced

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
2017 Standout

Author Peers

Author Last Decade Papers Cites
Suzanne George 6644 3812 3579 255 11.4k
Axel Le Cesne 9466 2449 6995 264 14.2k
Peter Hohenberger 8759 3914 4938 363 13.4k
Chandrajit P. Raut 5882 2273 4167 199 9.2k
Margaret von Mehren 10412 8993 3982 282 15.9k
William D. Tap 5082 930 3740 283 8.4k
Paolo G. Casali 18356 6359 8147 424 24.0k
Antoîne Italiano 8842 649 8717 606 16.8k
A. Norman 5781 1025 5789 137 12.1k
Agnieszka Woźniak 3294 1916 1523 181 5.1k
A.T. van Oosterom 2865 568 3735 176 7.7k

All Works

Loading papers...

Rankless by CCL
2026